Pinsent Masons hires Life Science partner in Dublin

11 Sep 2023 | 09:40 am | 1 min. read

Multinational law firm Pinsent Masons has hired transactional life sciences specialist Michael Stewart as partner in its Dublin office as it expands its pan-European Technology, Science and Industry (TSI) capabilities.

Michael is a leading life sciences lawyer, specialising in corporate transactional projects including M&A, assets sales and purchases, corporate finance and licensing and collaboration deals. 

Joining from Novartis, where he was most recently Lead Counsel in the group transactions team, Michael previously held roles as Global Head of Legal Strategic Transactions & Established Medicines in the company’s pharmaceuticals division and senior counsel in the Group M&A team. 

Michael is the fifth partner to join the firm’s TSI sector this year following IP life sciences expert Kristina Cornish, data and information law partner Jaya Handa, TMT cyber specialist Eleanor Ludlam and patent litigator James Marshall

Head of IP and Life Sciences at Pinsent Masons, Clare Tunstall, said: “Michael has acted on some of the biggest transactions in the sector. His in-house and private practice expertise will have a significant impact on our multinational life sciences capabilities and in particular will enhance our on the ground sector offering in Dublin. 

“High growth biotech and medtech start-ups play a pivotal role in the pharmaceuticals industry and we are confident that Michael’s expertise will enable us to further tap into this vibrant market.”

During his time at Novartis, Michael worked on major transactions including the spin-off by Novartis of Alcon (its eye care division), the acquisition by Sandoz of the Japan based generics business of Aspen Pharmacare Holdings and most recently, the announced sale by Novartis of Xiidra (a product for the treatment of dry eye disease) to Bausch + Lomb.

Commenting on his move Michael said: “After seven years in-house I am very excited to move back to private practice and continue my career at Pinsent Masons. The firm’s reputation as a leader in life sciences legal services, its stellar client base and depth of expertise will be an excellent platform that will enable me to build a thriving cross border practice.”

Latest press releases

Show me all press releases

Pinsent Masons advises Poundland on major restructuring plan

Multinational law firm Pinsent Masons has advised the board of Poundland Limited in relation to its restructuring plan (sanctioned by the High Court on 26 August 2025) and related financing arrangements.

Pinsent Masons hires leading funds partner in Luxembourg

Multinational law firm Pinsent Masons has today announced the hire of Manfred Dietrich to lead its funds and asset management team in Luxembourg.

Pinsent Masons adds leading energy partner in Australia

Multinational law firm Pinsent Masons continues to build on its strong energy sector expertise with the appointment of Nick Li as a partner in its corporate team in Melbourne.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons adds leading energy partner in Australia

Multinational law firm Pinsent Masons continues to build on its strong energy sector expertise with the appointment of Nick Li as a partner in its corporate team in Melbourne.

Pinsent Masons launches new tool to transform legal due diligence reporting

Multinational law firm Pinsent Masons has launched a new online platform to radically streamline the legal due diligence reporting process during complex M&A transactions.

Pinsent Masons bolsters mergers and acquisitions expertise with major UK team hire

Multinational law firm Pinsent Masons has today announced that its corporate bench in Manchester is set to grow with the hire of three leading M&A partners from EY.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.